[1]刘阔.莫沙必利联合复方消化酶治疗老年餐后不适综合征型功能性消化不良的效果观察[J].中国实用乡村医生杂志,2020,27(02):39-41,44.[doi:10.3969/j.issn.1672-7185.2020.02.015]
 LIU Kuo.Effect of Mosapride Combined with Compound Digestive Enzymes on Functional Dyspepsia in Elderly Patients with Postprandial Discomfort Syndrome[J].Chinese Practical Journal of Rural Doctor,2020,27(02):39-41,44.[doi:10.3969/j.issn.1672-7185.2020.02.015]
点击复制

莫沙必利联合复方消化酶治疗老年餐后不适综合征型功能性消化不良的效果观察()
分享到:

《中国实用乡村医生杂志》[ISSN:1672-7185/CN:21-1502/R]

卷:
27
期数:
2020年02期
页码:
39-41,44
栏目:
论著
出版日期:
2020-02-15

文章信息/Info

Title:
Effect of Mosapride Combined with Compound Digestive Enzymes on Functional Dyspepsia in Elderly Patients with Postprandial Discomfort Syndrome
文章编号:
1672-7185(2020)02-0039-04
作者:
刘阔
作者单位:110031 沈阳,沈阳市大众医院
Author(s):
LIU Kuo
(Shenyang Dazhong Hospital, Shenyang 110031, Liaoning Province, China)
关键词:
功能性消化不良餐后不适综合征药物治疗莫沙必利复方消化酶效果
Keywords:
Functional Dyspepsia Postprandial Discomfort Syndrome Drug Therapy Mosapride Compound Digestive Enzymes Effect
分类号:
R57
DOI:
10.3969/j.issn.1672-7185.2020.02.015
文献标志码:
A
摘要:
目的 探讨莫沙必利联合复方消化酶治疗老年餐后不适综合征型功能性消化不良的效果。方法 选取2018年1月—2019年1月在沈阳市大众医院进行治疗的老年餐后不适综合征型功能性消化不良患者53例,依据治疗方法的不同分为观察组26例和对照组27例,对照组给予莫沙必利治疗,观察组给予莫沙必利联合复方消化酶治疗,比较两组的治疗效果。结果 治疗总有效率观察组为92.3%,高于对照组的81.5%,但两组差异无统计学意义(P>0.05)。观察组不良反应发生率为15.4%,高于对照组的7.4%,但两组差异无统计学意义(P>0.05)。观察组功能性消化不良生活质量量表各维度评分和总分均高于对照组,差异有统计学意义(P<0.05)。结论 对于老年餐后不适综合征型功能性消化不良患者,在莫沙必利治疗基础上给予复方消化酶,能够提高疗效和患者生活质量,且不会增加不良反应,值得推广使用。
Abstract:
Objective To investigate the clinical effect of Mosapride combined with compound digestive enzymes in the treatment of functional dyspepsia in elderly patients with postprandial discomfort syndrome. Methods A total of 53 elderly patients with functional dyspepsia with postprandial discomfort syndrome were selected from January 2018 to January 2019 in Shenyang Public Hospital. According to the different treatment methods, they were divided into observation group (26 cases) and control group (27 cases). The control group was treated with mosapride, while the observation group was treated with Mosapride combined with compound digestive enzymes. Therapeutic effect was observed and compared between the two groups. Results The total effective rate was 92.3% in the observation group, which was higher than 81.5% in the control group (P>0.05). The incidence of adverse reactions in the observation group was 15.4%, higher than 7.4% in the control group (P>0.05). The scores of each dimension and total score of the functional dyspepsia quality of life scale in the observation group were significantly higher than those in the control group (P<0.05). Conclusion For elderly patients with functional dyspepsia of postprandial discomfort syndrome, mosapride combined with compound digestive enzymes can improve the curative effect and the quality of life without increasing adverse reactions. It is worth popularizing.

参考文献/References:

[1] 中国中西医结合学会消化系统疾病专业委员会.功能性消化不良中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2017,25(12):889-894.
[2] 中华医学会消化病学分会胃肠动力学组,中华医学会消化病学分会胃肠功能性疾病协作组.中国功能性消化不良专家共识意见(2015年,上海)[J].中华消化杂志,2016,36(4):217-229.
[3] 中华医学会老年医学分会老年消化学组.消化酶制剂在老年人消化不良中应用中国专家共识(2018)[J].中华老年医学杂志,2018,37(6):605-611.
[4] 徐三荣.功能性胃肠道疾病罗马诊断标准的历史变迁及标准Ⅳ[ J].中华诊断学电子杂志,2016,4(3):184--190.
[5]陈姗,罗莎,司丽丽,等.老年功能性消化不良的中西医研究概况[J].中国民族民间医药,2018,27(5):67-69.
[6] 李小雯,郑松柏.老年人消化道动力异常及其机制研究进展[J].胃肠病学,2014,12(12):746-749.
[7] 左芳,褚传莲,王长梅.莫沙必利联合复方消化酶治疗老年功能性消化不良疗效与安全性分析[ J].中外医疗,2015,35(34):136-137.

备注/Memo

备注/Memo:
收稿日期:2019-08-08)

更新日期/Last Update: 2020-03-10